Shopping Cart 0
Cart Subtotal
USD 0

Global Transdermal Patch Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2980

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5960

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

The global Transdermal Patch market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Transdermal Patch by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Fentanyl Transdermal Patch

Nicotine Transdermal Patch

Buprenorphine Transdermal Patch

Clonidine Transdermal Patch

Oxybutynin Transdermal Patch

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Hisamitsu Pharmaceutical

Novartis

Johnson & Johnson

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.

Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Transdermal Patch Industry

1.1.1 Overview

1.1.2 Development of Transdermal Patch

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Transdermal Patch Market by Type

3.1 By Type

3.1.1 Fentanyl Transdermal Patch

3.1.2 Nicotine Transdermal Patch

3.1.3 Buprenorphine Transdermal Patch

3.1.4 Clonidine Transdermal Patch

3.1.5 Oxybutynin Transdermal Patch

3.1.6 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Transdermal Patch Hisamitsu Pharmaceutical (Company Profile, Sales Data etc.)

4.2 Novartis (Company Profile, Sales Data etc.)

4.3 Johnson & Johnson (Company Profile, Sales Data etc.)

4.4 Teikoku Pharma (Company Profile, Sales Data etc.)

4.5 Mylan (Company Profile, Sales Data etc.)

4.6 Actavis (Company Profile, Sales Data etc.)

4.7 Mundipharma (Company Profile, Sales Data etc.)

4.8 Henan Lingrui Pharmaceutical (Company Profile, Sales Data etc.)

4.9 Changzhou Siyao (Company Profile, Sales Data etc.)

4.10 Rfl Pharmaceutical (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

6.1.2 Demand in Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

6.1.3 Demand in Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

6.1.4 Demand in Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.

6.1.5 Demand in Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

6.1.6 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Transdermal Patch Market Growth 2013-2018, by Type, in USD Million

Figure Global Transdermal Patch Market Growth 2013-2018, by Type, in Volume

Figure North America Transdermal Patch Market Concentration, in 2018

Figure Europe Transdermal Patch Market Market Concentration, in 2018

Figure Asia-Pacific Transdermal Patch MMarket Concentration, in 2018

Figure South America Transdermal Patch Market Concentration, in 2018

Figure Middle East & Africa Transdermal Patch Market Concentration, in 2018

Figure Transdermal Patch Demand in The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time., 2013-2018, in USD Million

Figure Transdermal Patch Demand in The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time., 2013-2018, in Volume

Figure Transdermal Patch Demand in Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped., 2013-2018, in Volume

Figure Transdermal Patch Demand in Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain., 2013-2018, in Volume

Figure Transdermal Patch Demand in Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body., 2013-2018, in Volume

Figure Transdermal Patch Demand in Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles., 2013-2018, in Volume

Figure Transdermal Patch Demand in Others, 2013-2018, in USD Million

Figure Transdermal Patch Demand in Others, 2013-2018, in Volume

Figure North America Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure North America Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Europe Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure Europe Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure South America Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure South America Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Transdermal Patch

Table Application Segment of Transdermal Patch

Table Global Transdermal Patch Market 2013-2024, by Application, in USD Million

Table Major Company List of Fentanyl Transdermal Patch

Table Major Company List of Nicotine Transdermal Patch

Table Major Company List of Buprenorphine Transdermal Patch

Table Major Company List of Clonidine Transdermal Patch

Table Major Company List of Oxybutynin Transdermal Patch

Table Major Company List of Others

Table Global Transdermal Patch Market 2013-2018, by Type, in USD Million

Table Global Transdermal Patch Market 2013-2018, by Type, in Volume

Table Global Transdermal Patch Market Forecast 2019-2024, by Type, in USD Million

Table Global Transdermal Patch Market Forecast 2019-2024, by Type, in Volume

Table Hisamitsu Pharmaceutical Overview List

Table Transdermal Patch Business Operation of Hisamitsu Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Transdermal Patch Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Transdermal Patch Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teikoku Pharma Overview List

Table Transdermal Patch Business Operation of Teikoku Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Transdermal Patch Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Actavis Overview List

Table Transdermal Patch Business Operation of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mundipharma Overview List

Table Transdermal Patch Business Operation of Mundipharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Henan Lingrui Pharmaceutical Overview List

Table Transdermal Patch Business Operation of Henan Lingrui Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Changzhou Siyao Overview List

Table Transdermal Patch Business Operation of Changzhou Siyao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Rfl Pharmaceutical Overview List

Table Transdermal Patch Business Operation of Rfl Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Transdermal Patch Sales Revenue 2013-2018, by Company, in USD Million

Table Global Transdermal Patch Sales Revenue Share, by Company, in USD Million

Table Global Transdermal Patch Sales Volume 2013-2018, by Company, in Volume

Table Global Transdermal Patch Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Transdermal Patch Demand Forecast 2019-2024, by Application, in USD Million

Table Transdermal Patch Demand Forecast 2019-2024, by Application, in Volume

Table Transdermal Patch Production 2013-2018, by Region, in USD Million

Table Transdermal Patch Production 2013-2018, by Region, in Volume

Table Global Transdermal Patch Market 2013-2018, by Region, in USD Million

Table Global Transdermal Patch Market Share 2013-2018, by Region, in USD Million

Table Global Transdermal Patch Market 2013-2018, by Region, in Volume

Table Global Transdermal Patch Market Share 2013-2018, by Region, in Volume

Table North America Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table North America Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Europe Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table Europe Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table South America Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table South America Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Transdermal Patch Market Forecast 2019-2024, by Region, in USD Million

Table Transdermal Patch Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Snapshot

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

The global Transdermal Patch market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Transdermal Patch by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Fentanyl Transdermal Patch

Nicotine Transdermal Patch

Buprenorphine Transdermal Patch

Clonidine Transdermal Patch

Oxybutynin Transdermal Patch

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Hisamitsu Pharmaceutical

Novartis

Johnson & Johnson

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.

Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Transdermal Patch Industry

1.1.1 Overview

1.1.2 Development of Transdermal Patch

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Transdermal Patch Market by Type

3.1 By Type

3.1.1 Fentanyl Transdermal Patch

3.1.2 Nicotine Transdermal Patch

3.1.3 Buprenorphine Transdermal Patch

3.1.4 Clonidine Transdermal Patch

3.1.5 Oxybutynin Transdermal Patch

3.1.6 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Transdermal Patch Hisamitsu Pharmaceutical (Company Profile, Sales Data etc.)

4.2 Novartis (Company Profile, Sales Data etc.)

4.3 Johnson & Johnson (Company Profile, Sales Data etc.)

4.4 Teikoku Pharma (Company Profile, Sales Data etc.)

4.5 Mylan (Company Profile, Sales Data etc.)

4.6 Actavis (Company Profile, Sales Data etc.)

4.7 Mundipharma (Company Profile, Sales Data etc.)

4.8 Henan Lingrui Pharmaceutical (Company Profile, Sales Data etc.)

4.9 Changzhou Siyao (Company Profile, Sales Data etc.)

4.10 Rfl Pharmaceutical (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

6.1.2 Demand in Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.

6.1.3 Demand in Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

6.1.4 Demand in Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.

6.1.5 Demand in Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

6.1.6 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Transdermal Patch Market Growth 2013-2018, by Type, in USD Million

Figure Global Transdermal Patch Market Growth 2013-2018, by Type, in Volume

Figure North America Transdermal Patch Market Concentration, in 2018

Figure Europe Transdermal Patch Market Market Concentration, in 2018

Figure Asia-Pacific Transdermal Patch MMarket Concentration, in 2018

Figure South America Transdermal Patch Market Concentration, in 2018

Figure Middle East & Africa Transdermal Patch Market Concentration, in 2018

Figure Transdermal Patch Demand in The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time., 2013-2018, in USD Million

Figure Transdermal Patch Demand in The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time., 2013-2018, in Volume

Figure Transdermal Patch Demand in Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped., 2013-2018, in Volume

Figure Transdermal Patch Demand in Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain., 2013-2018, in Volume

Figure Transdermal Patch Demand in Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body., 2013-2018, in Volume

Figure Transdermal Patch Demand in Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles., 2013-2018, in USD Million

Figure Transdermal Patch Demand in Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles., 2013-2018, in Volume

Figure Transdermal Patch Demand in Others, 2013-2018, in USD Million

Figure Transdermal Patch Demand in Others, 2013-2018, in Volume

Figure North America Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure North America Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Europe Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure Europe Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure South America Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure South America Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Transdermal Patch Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Transdermal Patch Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Transdermal Patch

Table Application Segment of Transdermal Patch

Table Global Transdermal Patch Market 2013-2024, by Application, in USD Million

Table Major Company List of Fentanyl Transdermal Patch

Table Major Company List of Nicotine Transdermal Patch

Table Major Company List of Buprenorphine Transdermal Patch

Table Major Company List of Clonidine Transdermal Patch

Table Major Company List of Oxybutynin Transdermal Patch

Table Major Company List of Others

Table Global Transdermal Patch Market 2013-2018, by Type, in USD Million

Table Global Transdermal Patch Market 2013-2018, by Type, in Volume

Table Global Transdermal Patch Market Forecast 2019-2024, by Type, in USD Million

Table Global Transdermal Patch Market Forecast 2019-2024, by Type, in Volume

Table Hisamitsu Pharmaceutical Overview List

Table Transdermal Patch Business Operation of Hisamitsu Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Transdermal Patch Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Transdermal Patch Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teikoku Pharma Overview List

Table Transdermal Patch Business Operation of Teikoku Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Transdermal Patch Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Actavis Overview List

Table Transdermal Patch Business Operation of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mundipharma Overview List

Table Transdermal Patch Business Operation of Mundipharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Henan Lingrui Pharmaceutical Overview List

Table Transdermal Patch Business Operation of Henan Lingrui Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Changzhou Siyao Overview List

Table Transdermal Patch Business Operation of Changzhou Siyao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Rfl Pharmaceutical Overview List

Table Transdermal Patch Business Operation of Rfl Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Transdermal Patch Sales Revenue 2013-2018, by Company, in USD Million

Table Global Transdermal Patch Sales Revenue Share, by Company, in USD Million

Table Global Transdermal Patch Sales Volume 2013-2018, by Company, in Volume

Table Global Transdermal Patch Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Transdermal Patch Demand Forecast 2019-2024, by Application, in USD Million

Table Transdermal Patch Demand Forecast 2019-2024, by Application, in Volume

Table Transdermal Patch Production 2013-2018, by Region, in USD Million

Table Transdermal Patch Production 2013-2018, by Region, in Volume

Table Global Transdermal Patch Market 2013-2018, by Region, in USD Million

Table Global Transdermal Patch Market Share 2013-2018, by Region, in USD Million

Table Global Transdermal Patch Market 2013-2018, by Region, in Volume

Table Global Transdermal Patch Market Share 2013-2018, by Region, in Volume

Table North America Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table North America Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Europe Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table Europe Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table South America Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table South America Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Transdermal Patch Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Transdermal Patch Market Size 2013-2018, by Country, in Volume

Table Transdermal Patch Market Forecast 2019-2024, by Region, in USD Million

Table Transdermal Patch Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com